Shares of Ambev S.A. (NYSE:ABEV) have earned an average rating of “Buy” from the six brokerages that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $6.20.

A number of brokerages recently commented on ABEV. Zacks Investment Research downgraded Ambev from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Barclays PLC restated a “hold” rating on shares of Ambev in a research report on Sunday, July 30th.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Great West Life Assurance Co. Can bought a new stake in Ambev during the 1st quarter valued at $427,000. Commerzbank Aktiengesellschaft FI boosted its position in Ambev by 30.4% during the 1st quarter. Commerzbank Aktiengesellschaft FI now owns 109,334 shares of the company’s stock valued at $630,000 after acquiring an additional 25,508 shares in the last quarter. Advisors Asset Management Inc. boosted its position in Ambev by 19.2% during the 1st quarter. Advisors Asset Management Inc. now owns 113,783 shares of the company’s stock valued at $655,000 after acquiring an additional 18,343 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its position in Ambev by 78.1% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 57,000 shares of the company’s stock valued at $330,000 after acquiring an additional 25,000 shares in the last quarter. Finally, US Bancorp DE boosted its position in Ambev by 16.2% during the 1st quarter. US Bancorp DE now owns 423,319 shares of the company’s stock valued at $2,439,000 after acquiring an additional 58,955 shares in the last quarter. Institutional investors own 7.29% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Ambev S.A. (ABEV) Receives Average Recommendation of “Buy” from Brokerages” was published by American Banking News and is owned by of American Banking News. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/09/09/ambev-s-a-abev-receives-average-recommendation-of-buy-from-brokerages.html.

Shares of Ambev (NYSE ABEV) opened at 6.43 on Friday. The stock’s 50 day moving average price is $6.17 and its 200-day moving average price is $5.80. The company has a market cap of $101.00 billion, a P/E ratio of 26.90 and a beta of 0.66. Ambev has a 12 month low of $4.70 and a 12 month high of $6.48.

Ambev (NYSE:ABEV) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.04 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.04. The firm had revenue of $3.20 billion during the quarter, compared to analyst estimates of $3.33 billion. Ambev had a return on equity of 23.24% and a net margin of 27.14%. Equities research analysts expect that Ambev will post $0.23 earnings per share for the current year.

Ambev Company Profile

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.

Receive News & Ratings for Ambev S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev S.A. and related companies with MarketBeat.com's FREE daily email newsletter.